KANE JOHN A 4
4 · Health Catalyst, Inc. · Filed Jul 29, 2019
Insider Transaction Report
Form 4
KANE JOHN A
Director
Transactions
- Conversion
Common Stock
2019-07-29+23,586→ 80,877 total - Conversion
Series F Preferred Stock
2019-07-29−589→ 0 total→ Common Stock (589 underlying) - Conversion
Common Stock
2019-07-29+589→ 81,466 total - Conversion
Series E Preferred Stock
2019-07-29−23,586→ 0 total→ Common Stock (23,586 underlying)
Footnotes (2)
- [F1]Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.
- [F2]Each share of Series F Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date.